DERIVATIVES OF 3-H-1,2,3-TRIAZOLO-[4,5-D]-PYRIMIDINE, PHARMACEUTICAL COMPOSITION AND METHOD OF THEIR SYNTHESIS Russian patent published in 2001 - IPC

Abstract RU 2174518 C2

FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to derivatives of 3-H-1,2,3-triazolo-[4,5-d] -pyrimidine of the general formula (I) where B means O or CH2; X is taken among NR1R2,SR1 and C1-C7-alkyl; Y is taken among SR1,NR1R2 and C1-C7-alkyl; R1 and R2 each means independently H or C1-C7-alkyl; or R1 means C1-C7-alkyl optionally substituted in alkyl chain with O or S or one or more halogen atoms and R2 means hydrogen atom; R3 and R4 both mean hydrogen atom or in common they form bons; A means COOH, C(O)NH-(CH)p-COOH, C(O)N[(CH2)q-COOH]2, C(O)NHCH-(COOH)-(CH2)r-COOH or 5-tetrazolyl where p, q and r each = 1, 2 or 3 independently and also their pharmaceutically acceptable salts or esters. Invention describes also method of synthesis of these compounds and pharmaceutical composition containing thereof. Claimed compounds prevent platelet aggregation. EFFECT: improved method of synthesis, valuable medicinal properties. 17 cl, 26 ex

Similar patents RU2174518C2

Title Year Author Number
TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, METHODS FOR THEIR PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITION 1998
  • Gajl Simon
  • Ingoll Ehntoni
  • Springtorp Brajan
  • Uillis Pol
RU2225407C2
NOVEL INTERMEDIATE COMPOUNDS FOR PRODUCING TRIAZOLO(4,5-d)PYRIMIDINE 2012
  • Gil Sajmon
  • Khardern Devid
  • Ingoll Entoni
  • Springtorp Brajan
  • Uillis Pol
RU2593201C2
NOVEL CRYSTALLINE FORM OF TRIAZOLO(4,5-d)PYRIMIDINE 2005
  • Bolin Martin
  • Kosgrouv Stiv
  • Lassen Bo
RU2418802C2
NEW CRYSTAL AND AMORPHOUS FORM OF TRYAZOL[4,5-d] PYRIMIDINE 2001
  • Bolin Martin
  • Kosgrouv Stiv
  • Lassen Bo
RU2325391C2
TRIAZOLO[4,5-d]PYRIMIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF AND METHOD FOR TREATMENT, METHOD FOR THEIR PREPARING AND INTERMEDIATE COMPOUNDS 1999
  • Gil Sajmon
  • Khardern Dehvid
  • Ingoll Ehntoni
  • Springtorp Brajan
  • Uillis Pol
RU2317990C2
2,6-DIAMINOPURINE--β--D-RIBOFURANURONAMIDE DERIVATIVES, METHOD OF PREPARING THEREOF, PHARMACEUTICAL COMPOSITION FOR SUPPRESSING ACTIVITY OF LEUKOCYTES, METHOD OF PREPARING PHARMACEUTICAL COMPOSITION, AND METHOD OF SUPPRESSING LEUKOCYTES 1994
  • Gregson Majkl
  • Ehjrz Berri Ehdvard
  • Ivan Dzhordzh Blehng
  • Ehllis Frehnk
  • Najt Dzhon
RU2129561C1
DERIVATIVES OF 7-(2-AMINOETHYL)-BENZOTHIAZOLONE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHODS OF THEIR SYNTHESIS, DERIVATIVES OF N-[2-(4-HYDROXY-2-OXO-3H-1,3-BENZOTHIAZOLE-7-YL]-ETHYLAMIDE, PHARMACEUTICAL COMPOSITION SHOWING AGONISTIC ACTIVITY RELATIVE TO β-ADRENORECEPTORS 1993
  • Rodzher Viktor Bonnert
  • Dehvid Rehnalf Cheshir
  • Rodzher Charl'Z Braun
  • Frehnsis Ins
RU2114108C1
CARDIOPROTECTIVE AGENT AND ITS COMPOSITION 1995
  • Al'Fred P. Spada
  • Sintia A. Fink
  • Majkl R. Majers
RU2166319C2
PYRIMIDINE COMPOUNDS, METHODS FOR THEIR PREPARING (VARIANTS), INTERMEDIATE SUBSTANCES (VARIANTS) AND METHODS FOR THEIR PREPARING (VARIANTS), METHOD FOR PREPARING TRIAZOLOPYRIMIDINE COMPOUNDS 2001
  • Larsson Ul'F
  • Magnusson Mattias
  • Musil' Tibor
  • Pal'Mgren Andreas
RU2295526C2
METHOD FOR OBTAINING [1S-[1α,2α,3β(1S*,2R*),5β]]-3-[7-[2-(3,4-DIFLUOROPHENYL)-CYCLOPROPYLAMINO]-5-(PROPYLTHIO)-3H-1,2,3-TRIAZOLO[4;5-d]PYRIMIDINE-3-YL]-5-(2-HYDROXYETHOXY)-CYCLOPENTANE-1,2-DIOL AND ITS INTERMEDIATE COMPOUNDS 2009
  • Aufdenblatten Roni
  • Bokhlin Martin Khans
  • Khellstrem Khelena
  • Jokhansson Peter V.
  • Larsson Ul'F G.
  • Reknagel' Mikaehla
  • Uehjss Andreas
RU2509082C2

RU 2 174 518 C2

Authors

Koks Dehvid

Ingoll Ehntoni

Uillis Pol

Dates

2001-10-10Published

1996-07-04Filed